SureTrader Nadex Advertisement PGUS
Home > Boards > US OTC > Medical - Healthcare >

Decision Diagnostics Corp. (DECN)

DECN RSS Feed
Add DECN Price Alert      Hide Sticky   Hide Intro
Moderator: Alydyr, nonsequetor, diannedawn, Cakes10
Search This Board: 
Last Post: 3/23/2017 11:53:28 AM - Followers: 211 - Board type: Free - Posts Today: 32

http://www.pharmatechdirect.com/products.html

http://www.decisiondiagnostics.com/



Global List of Online Retailers for PharmaTech Solutions, Inc. Products (.pdf)




*RECENT PRESS RELEASES*

 

DECN Press Releases

 

November 2016

DECN Opens International Markets for Popular Genultimate!, Increases Factory Capacity (Nov 30)


October 2016

Decision Diagnostics Reports on the Achievements and Success of Genultimate!

http://www.otcmarkets.com/news/otc-market-headline?id=630111

August 2016

DECN Litigation Victory Against Johnson + Johnson, Launches Foothold in On-Line Retail Markets for Its Popular "Gen" Products (Aug 23)

July 2016

Decision Diagnostics Ends Plans and Communications With Tauriga Sciences, Inc. Concerning Possible Reverse Merger Transaction (Jul 1)

June 2016

Decision Diagnostics Emerges Victorious in End to Acrimonious Patent Litigation With Divisions of Johnson + Johnson (Jun 2)

May 2016

Decision Diagnostics Nears Positive Ending of Its California Patent and Trademark Infringement Litigation With Divisions of Johnson + Johnson (May 12)

Download Available: Federal Circuit Court Order Denying Appeal made by Lifescan and Johnson & Johnson and imposing mandate on May 17, 2016

Download Available: Schedule Report for GenStrip50 TV Advertising (May 1)

April 2016

Download Available: Schedule Report for GenStrip50 TV Advertising (Apr 25)

Forbes Article: David-Goliath Fight Over Glucose Tests For Diabetics Hits Boiling Point (Apr 20)

Decision Diagnostics Engages Retail Monster LLC to Procure Big Box Retailers for Company's GenUltimate Product (Apr 14)

March 2016

Decision Diagnostics and Subsidiaries Elaborate on the Patent Infringement Lawsuit Against Johnson & Johnson and Two of Its Divisions (Mar 16)

DECN Subsidiaries Sue Johnson & Johnson and Several Divisions for Patent Infringement (Mar 14)

February 2016

Decision Diagnostics Conveys Opportunities and Potential Following Landmark Circuit Court Ruling Against Diabetes Testing Division of Johnson & Johnson (Feb 9)

January 2016

DECN Assesses Its Recent Landmark Legal Victories Over Diabetes Division Of Johnson & Johnson (Jan 28)

Decision Diagnostics Wins Federal Appeals Court Victory, Ruling Affirms J&J Division's Loss of US Patent No. 7,250,105 (Jan 21)

We Win! United States Court of Appeals for the Federal Circuit - Opinion Filed for LifeScan Scotland, Ltd. v. Pharmatech Solutions, Inc. (Jan 20)

 

 

December 2015

Download Available: United States Court of Appeals for the Federal Circuit - Oral Argument Recording for LifeScan Scotland, Ltd. v. Pharmatech Solutions, Inc. (Dec 18)

June 2015

Decision Diagnostics Completes Investment in Korean R+D and Contract Manufacturing Partner (Jun 15)

Decision Diagnostics Executes Broad Manufacturing and R+D Agreement With Korean Manufacturer (Jun 4)

May 2015

Decision Diagnostics States Johnson & Johnson Division Offers Partial Surrender in Long Running Patent Battle (May 19)

Decision Diagnostics Files Application for Uplisting to OTCMarkets OTCQX (May 12)

April 2015

Decision Diagnostics Shrugs Off New Attack As Johnson & Johnson Panics In Patent Case (Apr 21)

U.S. Solicitor General Intervenes Against Johnson & Johnson in DECN's Long Running Patent Battle Over GenStrip 50 (Apr 14)

March 2015

Johnson & Johnson Division Attempts Final Appeal in Effort to Overturn Multiple USPTO Decisions Issued in DECN's Favor (Mar 31)

Decision Diagnostics Rejects Settlement Offers From J&J/Lifescan, Company's Prosecutions of Court Bond and Anti-Trust Actions Now Move On (Mar 4)

January 2015

Updated TV Commercial Fulfillment (Jan 20)

DECN Plans New Legal Challenge After LifeScan (J&J) Admits to Using Sworn Testimony From Expert With Falsified Credentials (Jan 14)

 

 

December 2014

DECN Initiates End Game Strategy For Litigation With Division Of Johnson & Johnson (Dec 3)

November 2014

DECN's Subsidiary Initiates First In Industry Social Media Marketing Campaign For Genstrip50 (Nov 5)

August 2014

David Defeats Goliath (Again), DECN and Pharma Tech Solutions Awarded Victory Over Johnson & Johnson Lifescan in USPTO Final Ruling (Aug 11)

David Beats Goliath in Patent Rematch (Aug 7)

June 2014

DECN's Pharma Tech Subsidiary Places Significant Order for 50,000 Units of Genstrip 50 for Immediate Delivery to Select U.S. and International Distributors (Jun 3)

May 2014

Decision Diagnostics Corp. Subsidiary Pharma Tech Enters International Markets With Conformité Européenne (CE) Mark Submission (May 29)

GenStrip Opportunity Expands Under Full Control of DECN's PharmaTech Division (May 1)

April 2014

Decision Diagnostics Responds to Shasta Technologies FDA Safety Warning Letter (Apr 30)

Decision Diagnostics Subsidiary Acquires GenStrip (Apr 16)

March 2014

Decision Diagnostics Announces Posting and Airing of Its New GenStrip Commercial Titled "Monolith"(Mar 31)

Decision Diagnostics Announces Engagement of Mark Krakauer to Head Up Genstrip Private Label Sales Efforts (Mar 11)

TV Commercials Fulfillment #3 (Mar 4)

February 2014

TV Commercials Fulfillment #2 (Feb 26)

Decision Diagnostics Announces Agreement for Funding of Its Prosecution of Anti-Trust and False Advertising Suits Against Division of Johnson & Johnson (Feb 18)

TV Commercials Fulfillment #1 (Feb 15)

January 2014

Decision Diagnostics Announces Posting and Airing of Its New GenStrip Commercial Titled "A Winter Patchwork" (Jan 15)

 

 

December 2013

Decision Diagnostics Closes $12.5 Million (Non-Dilutive) Credit Facility With Division of Platinum Credit Management (Dec 19)

Decision Diagnostics Starts its Turnaround (Dec 17)

Decision Diagnostics Receives Mandate From U.S. Court of Appeals for the Federal Circuit in the Long Running Dispute With J&J Division (Dec 17)

Mandate from Federal Appeals Court (.pdf) (Dec 11)

Decision Diagnostics' Board Votes to Uplist to OTC QX (Dec 10)

November 2013

Decision Diagnostics Takes Victory In Major Case Ruling (Nov 11)

Diabetes: J&J loses a round in glucose testing battle with Shasta (Nov 7)

Decision Diagnostics On Track For Growth And Increased Revenues (Nov 7)

DECN And Pharma Tech Solutions Receive Anticipated Ruling From The U.S. Federal Circuit Court Of Appeals, Reversing A Ruling By Lower Court Judge (Nov 5)

DECN Wins Only Case That Matters in Federal Circuit Court (.pdf) (Nov 4)

October 2013

Well Ahead Of Schedule, Decision Diagnostic's Pharma Tech Division Completes First Major Shipments Of Its Popular Genstrip Test Strip (Oct 31)

Decision Diagnostics Receives Signed Term Sheet Agreement For $12.5 Million Revolving Credit Facility Which Will Complete DECN’s GenStrip Roll-Out Plan (Oct 29)

Decision Diagnostics Could Be The New Vringo (Oct 24)

Recognized Healthcare And Financial Publications Acknowledge Decision Diagnostics’ GenStrip Market Potential (Oct 22)

DECN Set To Climb As GenStrip Enters Blood Glucose Monitoring Market With First Shipments (Oct 22)

Decision Diagnostic Blood Glucose Test Strip Technology Enters Market with Genstrip (Oct 22)

Court Ruling for Decision Diagnostics Order Staying Proceedings (.pdf) (Oct 9)

Decision Diagnostics' Pharma Tech Division Schedules Shipments For Its Popular GenStrip Test Strip (Oct 3)

Decision Diagnostics' Pharma Tech Division Schedules Large Order Shipments for Its Popular GenStrip Test Strip (Oct 1)

September 2013

David And Goliath Case Offers A Surprising Opportunity (Sep 26)

J&J feels Decision Diagnostics' sting in glucose strip patent fight (Sep 12)

J&J's Blood Sugar Testing Patent Spat Turns Sour (Sep 12)

J&J Seeks Court Aid To Protect Its Glucose Monitoring Test (Sep 11)

Decision Diagnostics Corp. Announces Completion and Airing of Its New Genstrip Video Titled "A Patchwork of Life" (Sep 10)

Decision Diagnostic's GenStrip Could Change the Blood Glucose Market (Sep 1)

August 2013

Court's Ruling on PharmaTech's Motion for Contempt (Aug 28)

GenStrip™ and USPTO Ruling (Aug 15)

Decision Diagnostics Subsidiary Makes Move and Sues Two Johnson and Johnson Divisions for False Advertising in Ongoing Battle (Aug 1)

May 2013

DECN Steps Into Role of White Knight by Offering Strategic Version of GenStrip™ Exclusively for Medicare Competitive Bidding Program (May 29)


  • Decision Diagnostics Corp. is saddened to announce the sudden passing of our long-time friend and Computer and Information Systems Manager, Mr. Alan B Binder (May 10)

April 2013

Decision Diagnostics Corp. and Its Subsidary PharmaTech Solutions Seek to End Pharma Giant's Alleged Restraint of Trade Tactics (Apr 5)

Decision Diagnostics Corp. and Its Subsidiary PharmaTech Solutions, Inc. Sue Johnson & Johnson Division LifeScan, Inc. and LifeScan Scotland Ltd. for Antitrust Violations (Apr 4)

March 2013

J&J Faces Potentially Disrupting Competition In Its Lucrative Glucose Monitoring Business From Tiny Diagnostics Outfit (Mar 11)

January 2013

FDA Review - Decision Summary (Jan 2)

FDA 510(k) Premarket Notification (Jan 2)

 

 

December 2012

FDA 510(K) Clearance Letter (Dec 5)

Opportunity and Market for Decision Diagnostics (OTCBB:DECN) Shasta GenStrip®; at home diagnostic for testing blood glucose (Dec 4)

November 2012

Medical Technology Stock Q&A with Decision Diagnostics (Nov 28)

Medical Technology Stock Decision Diagnostics Lead Product Shasta Genstrip Positions for at-home testing of Blood Glucose Market (Nov 21)

Decision Diagnostics Set to Become Force in at-home testing of blood glucose, estimated $22.5 Billion Worldwide (Nov 16)

January 2012

Decision Diagnostics Corp. is saddened to announce the passing of our friend and financial guidance advisor, Mr. William N. Walling, Jr. (Jan 18)

Medical IT and Diagnostic Product Company Decision Diagnostics Announces Patent Enforcement Strategy for Their Smart Phone Based EMR Technology (Jan 11)

 

 

December 2011

Decision Diagnostic Corp. Clarifies 10% Stock Dividend, Announces Patent Enforcement Strategy (Dec 27)

Decision Diagnostic Corp. (Formerly InstaCare) Announces 10% Stock Dividend (Dec 6)

Instacare Changes Name to Decision Diagnostics Corp.; Will Apply for Nasdaq Bx Exchange Listing (Dec 1)

May 2011

Instacare Corp. Board of Directors Considers Recent Merger Proposal Inadequate (May 11)

InstaCare Corp. Receives Second Confidential Merger Offer From NASDAQ Traded Company (May 9)

April 2011

InstaCare Subsidiary Signs New Agreement for Expanded Management and Sales of Shasta Genstrip Into the $20 Billion Worldwide Diabetes Testing Market (Apr 18)

March 2011

 Download Hudson Securities - OTC Bulletin Board (.pdf) (Mar 11)

[email protected] coming soon!

InstaCare Announces Ready for Market [email protected] Mobile Health Media System for Pharmaceutical e-Detailing (Mar 10)

InstaCare Extends [email protected] & [email protected] Mobile EMR/EHR Technology to Smart Pad Systems (Mar 3)

InstaCare Announces Receipt of Technology and Patent Value Analysis Penned by Joseph Wolf, Ph.D and William Walling, CFA (Mar 2)

February 2011

InstaCare Files Full Utility Patent for [email protected] & [email protected] Technologies (Feb 28)

 

 

June 2010

InstaCare Subsidiary Inks 5-Year Exclusive Pact for Distribution of Proprietary Diabetes Test Strip Into $9.8 Billion Testing Market (Jun 24)

InstaCare Retains Martin E. Janis & Company, Inc. to Launch Nationwide Comprehensive IR/PR Program(Jun 3)

March 2010

Instacare Corp. Files Patent Application for its [email protected] Cell Phone Centric Technologies (Mar 2)

February 2010

instaCare Corp. Announces Launch of Infomercial Marketing Strategy (Feb 2)

January 2010

Download Available: Instacare Corp. States Conference Call on January 27 is a Success - Click here to download Conference Call (.mp3) (Jan 27)

Instacare Corp. Announces Details of Conference Call on January 27 (Jan 25)

instaCare Corp. Finalizes [email protected] Parallel Marketing Strategy (Jan 25)

DownLoad Available: Download Chairman's Letter to Stockholders(.pdf) (Jan 20)

instaCare Corp. Elects William Lyons to Its Board of Directors (Jan 14)

instaCare Corp. Finalizes [email protected] Parallel Marketing Strategy (Jan 12)

Instacare Corp. to Host Shareholder Conference Call on January 27, 2010 to Discuss Recent Events (Jan 4)

 

 

December 2009

Instacare Corp. Board of Directors Sets Growth Plans for 2010 (Dec 17)

Instacare Moves to Secure Patents for Its Newest Technologies, Announces Parallel Strategies for Its Revolutionary [email protected] Cell-Centric Products (Dec 3)

November 2009

instaCare in Renewal and Increase of its $2 Million Monthly Revolving Credit Facility With Centurion Credit Resources, LLC (Nov 30)

ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes (Nov 23)

instaCare Corp. Continues Turnaround, Reports 58% Revenues Increase for First Three Quarters (Nov 18)

 

 

May 2008

InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 (May 21)

 

September 2007

InstaCare Corp. Reviewing M&A Plans (Sep 26)

April 2007

Instacare Corp. Announces Expanded Product Lines, Group Vendor Agreements and Enhanced Customer Base (Apr 04)

 

July 2006

InstaCare Corp. in Contract Deliberations With Mexican Government Health Institute ISSSTE for E-Health Implementation Pact (Jul 20)

InstaCare Receives Enhanced Targets and Rating From Wasserman Morris in Latest Research Report (Jul 17)

May 2006

instaCare Corp. to Hold Conference Call May 25, 2006 (May 23)

 

September 2005

instaCare Corp. Comments on Recent Significant News Concerning the Efficacy of Cost Saving Wireless Technologies in Healthcare (Sep 13)

 

 

 

Decision Diagnostics is a leading developer of smart phone based remote Electronic Medical Record technologies.

Decision Diagnostics is a prescription and non-prescription diagnostics and home testing products distributor. We distribute brand name rx and non-rx diagnostics products, as well as several lines of ostomy, wound care and post-surgery medical products. Our line of devices for blood glucose home testing include Genstrip50 and Discretion. We proudly provide IT services in several medical care market channels by providing physicians with information at the point of care through the use of smart cell phones as the information delivery vehicle that allow physicians to carry, access and update their patients' histories, medication data, and care guidelines.

Discretion Companion

Wireless Enabled Blood Glucose Self-Test Kit

Discretion Companion is a revolutionary new diabetes monitoring and wireless communication device. It was designed to ensure the health and safely of those you hold most precious -- your children.

 

Discretion Companion
 

Discretion Messenger

Blood Glucose Self-Monitoring System

Discretion Messenger Blood Glucose Monitoring System is designed to pursuit the accuracy in blood glucose monitoring to provide you with easy and comfortable testing. The system requires 0.5μL of blood sample and 5 seconds for the test to complete.

 
Concept Designs, progress development

GenStrip50

For use with the OneTouch Ultra family of meters

 

GenStrip50 is the #1 affordable option for testing with the OneTouch Ultra family of meters. Users of Ultra meters who switch to GenStrip50 enjoy paying 80% less then the name-brand strips. GenStrip50 is safe to use, approved for use by the FDA, and made in the USA.

GenStrip50

GenUltimate Meter

PharmaTech Solutions's own low-cost blood glucose testing meter - for international markets.

GenUltimate is the #1 affordable option for blood glucose testing. GenUltimate is safe to use, affordable, and usesGenStrip50 low-cost test strips.

More information coming soon!

GenUltimate Meter
GenUltimate!

GenUltimate! - Available Very Soon

PharmaTech Solutions, Inc. is excited to announce the completion of a test strip, based entirely on our Genstrip 50 design for sale beginning in March 2016.

GenUltimate! will be available in sunny new packaging and with new pricing. GenUltimate! sales will be initially directed toward large GPOs, chain pharmacies and large retailers.
FDA Cleared. It's a GenStrip.
PharmaTech Solutions is dedicated to bringing the latest technologies to diabetics at a reasonable cost.


GENSTRIP 50 WEBSITE:

http://www.new-genstrip.com/

 

  

 

GenStripTM is for use only with new LifeScan® Ultra®, Ultra®2, and UltraMini® meters you already own
Priced significantly lower than the existing consumable provided by the platform manufacturer
Available in quantities of 50 test strips
GenStrip is covered by Medicare Parts B & D, major health issuers, and major HMO and PPO benefits
Costs about 50% less than the Branded product without any sacrifice on quality for the "un-insured" or "under-insured" diabetic.
Now manufactured by PharmaTech - not to be confused with Shasta product; Made in the USA! GenStrip50 is safe to use and approved by the FDA
  
 



 

 

 


 

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
DECN
Current Price
Volume:
Bid Ask Day's Range
SureTrader
DECN News: Amended Statement of Ownership (sc 13g/a) 02/13/2017 05:00:48 PM
PostSubject
#42315  Sticky Note NEWBIES - DECN = DISASTER - LOOK AT CHART Alydyr 03/21/17 04:16:49 PM
#41322  Sticky Note **WOW** **WOW** **WOW** **WOW**!!!! nonsequetor 02/08/17 11:55:51 AM
#42461   Thanks, Nons! We have to be careful with DirkEaston 03/23/17 11:53:28 AM
#42460   "Good assessment" on a Korean contract that is nonsequetor 03/23/17 11:28:44 AM
#42458   Why does everyone need to hold forever? Hedgefundstrader 03/23/17 11:25:22 AM
#42457   Exactly. Just like the greyhound dog at Alydyr 03/23/17 11:20:57 AM
#42456   If you are interested you should ask them Hedgefundstrader 03/23/17 11:18:17 AM
#42455   Great, where is it? Did Fox Rothschild Alydyr 03/23/17 11:15:06 AM
#42454   Fox Rothschild came up with the $400-$700M Hedgefundstrader 03/23/17 11:12:55 AM
#42453   Good assessment Alydyr! zalicuslicious 03/23/17 10:52:22 AM
#42452   There is no answer to that as simple zeynoc 03/23/17 10:48:14 AM
#42451   Alydyr, that really does not make any sense nonsequetor 03/23/17 10:45:53 AM
#42450   Alydyr, can you explain your statement: nonsequetor 03/23/17 10:44:14 AM
#42449   The business is to convince the small shareholders Alydyr 03/23/17 10:43:28 AM
#42448   Like I've been saying all along....dead money. Flippers zalicuslicious 03/23/17 10:41:36 AM
#42447   So, there is business after all... nonsequetor 03/23/17 10:41:05 AM
#42446   Yes Lifescan thought so too and prevented a zeynoc 03/23/17 10:39:00 AM
#42445   Those "businesses" lose money. They lose a Alydyr 03/23/17 10:33:52 AM
#42444   No business here? nonsequetor 03/23/17 10:30:38 AM
#42443   You answered your own question. There has not zeynoc 03/23/17 10:30:06 AM
#42442   This is not a business model here. Alydyr 03/23/17 10:22:52 AM
#42441   Alydyr, aren't you the one that said... DirkEaston 03/23/17 10:12:13 AM
#42440   In these cases, you run a business model, zeynoc 03/23/17 10:11:46 AM
#42439   Who came up with this $400-700 million number? Alydyr 03/23/17 09:49:31 AM
#42438   Until almost a month ago, the sword was zeynoc 03/23/17 08:55:58 AM
#42437   Public companies are supposed to be democracies. ksviking12 03/23/17 08:53:14 AM
#42436   Who cares about the packaging, We purchased them, sal32647 03/23/17 06:52:52 AM
#42435   gman-one needn't be a packaging expert to see diarch 03/23/17 06:37:57 AM
#42434   Excellent summary of what I have been saying zeynoc 03/23/17 03:41:40 AM
#42433   I dare say evolution is primarily the gathering jtsmgoblue 03/23/17 03:00:19 AM
#42432   Read once more you will understand. Just for zeynoc 03/23/17 02:06:09 AM
#42431   $400-700mn award potential sure gives me personal satisfaction zeynoc 03/23/17 01:59:16 AM
#42430   goblue-temporal context is a factor in playing Decn. diarch 03/23/17 12:07:41 AM
#42429   "We will see but these levels and volumes scoop9 03/22/17 08:16:51 PM
#42428   The only error I made was thinking DECN's scoop9 03/22/17 08:13:58 PM
#42427   And I want in...lol northitgoes 03/22/17 08:12:30 PM
#42425   Hmmm. I recommend you invest in Fortune jtsmgoblue 03/22/17 07:43:36 PM
#42424   It was? scoop9 03/22/17 07:35:16 PM
#42423   Good post muncitorul 03/22/17 07:28:47 PM
#42422   If that kind of "personal satisfaction" is what scoop9 03/22/17 07:11:34 PM
#42421   Doesn't take a genius to confirm the opportunity mongoosevsgt 03/22/17 06:26:09 PM
#42420   Good thing you're the packaging expert... gman3 03/22/17 05:45:05 PM
#42419   "But most of all they have more morals diarch 03/22/17 04:44:54 PM
#42418   I have read posts from packaging experts, marketing zoran 03/22/17 04:38:40 PM
#42417   When that statement is made, a sell side zeynoc 03/22/17 04:38:12 PM
#42416   You know they are selling for sure? gman3 03/22/17 04:33:12 PM
#42415   Not really. The only thing I know is zeynoc 03/22/17 04:29:39 PM
#42414   Maybe the amended complaint will make it more gman3 03/22/17 04:26:52 PM
#42413   The chances of J&J settlement will increase then zeynoc 03/22/17 04:21:22 PM
#42412   Care to share any thoughts why you think gman3 03/22/17 04:18:37 PM
#42411   That makes two of us. Good luck. zeynoc 03/22/17 04:16:03 PM
#42410   Don't worry too much about the speed of zeynoc 03/22/17 04:13:10 PM
PostSubject